Songbai Liu

Suzhou Vocational Health College, Jiangsu Province Engineering Research Center of Molecular Target Therapy and Companion Diagnostics in Oncology, Suzhou Key Laboratory of Medical Biotechnology

Prof. Dr. Songbai Liu is head of Suzhou Key Laboratory of Medical Biotechnology and one of the research direction Leaders in Jiangsu Province Engineering Research Center of Molecular Target Therapy and Companion Diagnostics in Oncology. His main research interests are mechanistic studies on tumorigenesis and drug resistance, DNA damage events as biomarkers for disease diagnosis and prognosis, and targeted inhibitor screening.He is also the Jiangsu Province “Qinglan Program” Academic Leader, Jiangsu Province “333 Program” High-Level Talent, and Jiangsu Province Youth High-level Medical Talent. He is a member of the Editorial Board of the Journal of Molecular and Clinical Oncology, BIOCELL, Medicine International and a guest reviewer editor of Frontiers in Oncology. He has published more than 60 academic papers and received 21 granted patents.

Min Li

Hunan Provincial Maternal and Child Health Care Hospital, University of South China; National Health Commission Key Laboratory of Birth Defect Research and Prevention, Institute of Biochemistry and Molecular Biology, Hengyang Medical school

Prof. Dr. Min Li is a professor at Institute of Biochemistry and Molecular Biology, Hengyang Medical school, University of South China. Her main research aims to understand how defects in DNA synthesis and repair contribute to cancer pathogenesis and aging. Specially, the main project of her laboratory focus on transcription-replication conflict associated with genome instability. Dr. Min Li is also a core member of National Health Commission Key Laboratory of Birth Defect Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha.

Haitao Sun

Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Medicinal Plant Development

Prof. Dr. Haitao Sun is a Principal Investigator of Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College. Her main research interests are mechanistic studies on DNA replication and DNA damage response, sister chromatid cohesion, tumorigenesis, tumor drug resistance and anti-cancer activities of medicinal plants. She is also on the list of National of High-Level of Talent Program. She is a member of Chinese Society for Cell Biology. She has published more than 10 academic papers in top journals, such as Science, Acta Pharmaceutica Sinica B, Trends Cell Biology, and received 3 patents. 

Di Xin

Zhejiang University School of Medicine, the First Affiliated Hospital, MOE Joint International Research Laboratory of Pancreatic Diseases, Zhejiang Provincial Key Laboratory of Pancreatic Disease, Department of Hepatobiliary and Pancreatic Surgery

Prof. Dr. Di Xin is a Principal Investigator of Zhejiang Provincial Key Laboratory of Pancreatic Disease and MOE Joint International Research Laboratory of Pancreatic Diseases at the First Affiliated Hospital of Zhejiang University School of Medicine. His main research interests are studies on the molecular mechanism of DNA damage repair and tumor development, and the role and molecular mechanism of molecules that maintain genomic stability in innate immunity. Dr. Di Xin is a core member of Hangzhou Leading Innovation and Entrepreneurship Team, a member of Chinese Association of Pancreatology, and a member of Chinese Society for Cell Biology, and a member of is DDRHD (the international symposium on DNA Damage Response & Human Disease) of the Chinese Society of Biochemistry and Molecular Biology.